Literature DB >> 1576067

Effects of flurbiprofen on renal function in patients with moderate renal insufficiency.

M D Murray1, P K Greene, D C Brater, A K Manatunga, S D Hall.   

Abstract

1. Renal function was assessed in eight patients with chronic renal insufficiency following the administration of flurbiprofen 50 mg as a single dose and after chronic administration of 50 mg four times daily for 8 and 27 days. Diet and fluid intake were controlled. 2. Inulin and creatinine clearances and urinary excretion of sodium were measured at baseline and every 20 min for at least 3 h after dosing. The time of the mean peak concentration of (S)-flurbiprofen was used to guide the analysis of the clearances. Creatinine clearance, urinary excretion of sodium, and serum sodium and potassium were also assessed for 24 h after the dose and on a daily basis. Body weight and blood pressure were measured on a daily basis. 3. Decrements in inulin and creatinine clearances were small and reversible within 3 h of an oral dose of flurbiprofen. Comparison of baseline clearances for the three study periods (first dose and at 8 and 27 days of chronic dosing) revealed a lack of chronic effect on glomerular filtration rate. 4. In contrast, flurbiprofen caused a substantial (73 to 86%) and progressive decrease in the urinary excretion of sodium that reached a nadir within 4-5 h after drug administration. However, comparison of baseline values did not differ, indicating that balance conditions had been re-established. 5. Results of 24 h assessments were in agreement with the clearance study results. Reduced urinary excretion of sodium appeared to be limited to the first few days of flurbiprofen administration.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1576067      PMCID: PMC1381327          DOI: 10.1111/j.1365-2125.1992.tb04056.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  24 in total

Review 1.  Clinical aspects of renal prostaglandins and NSAID therapy.

Authors:  D C Brater
Journal:  Semin Arthritis Rheum       Date:  1988-02       Impact factor: 5.532

Review 2.  Renal syndromes associated with nonsteroidal antiinflammatory drugs.

Authors:  D M Clive; J S Stoff
Journal:  N Engl J Med       Date:  1984-03-01       Impact factor: 91.245

3.  Effects of sulindac and naproxen on prostaglandin excretion in patients with impaired renal function and rheumatoid arthritis.

Authors:  L O Eriksson; G Sturfelt; H Thysell; F A Wollheim
Journal:  Am J Med       Date:  1990-09       Impact factor: 4.965

4.  Renal effects of ibuprofen, piroxicam, and sulindac in patients with asymptomatic renal failure. A prospective, randomized, crossover comparison.

Authors:  A Whelton; R L Stout; P S Spilman; D K Klassen
Journal:  Ann Intern Med       Date:  1990-04-15       Impact factor: 25.391

5.  Acute and chronic effects of sulindac on renal function in chronic renal disease.

Authors:  C P Swainson; P Griffiths
Journal:  Clin Pharmacol Ther       Date:  1985-03       Impact factor: 6.875

6.  Effects of acute and chronic dosing of NSAIDs in patients with renal insufficiency.

Authors:  R D Toto; S A Anderson; D Brown-Cartwright; J P Kokko; D C Brater
Journal:  Kidney Int       Date:  1986-11       Impact factor: 10.612

7.  Nephron site of effect of nonsteroidal anti-inflammatory drugs on solute excretion in humans.

Authors:  S Kaojarern; P Chennavasin; S Anderson; D C Brater
Journal:  Am J Physiol       Date:  1983-02

8.  Functional significance of renal prostacyclin and thromboxane A2 production in patients with systemic lupus erythematosus.

Authors:  C Patrono; G Ciabattoni; G Remuzzi; E Gotti; S Bombardieri; O Di Munno; G Tartarelli; G A Cinotti; B M Simonetti; A Pierucci
Journal:  J Clin Invest       Date:  1985-09       Impact factor: 14.808

9.  Effects of sulindac and ibuprofen in patients with chronic glomerular disease. Evidence for the dependence of renal function on prostacyclin.

Authors:  G Ciabattoni; G A Cinotti; A Pierucci; B M Simonetti; M Manzi; F Pugliese; P Barsotti; G Pecci; F Taggi; C Patrono
Journal:  N Engl J Med       Date:  1984-02-02       Impact factor: 91.245

10.  Prostaglandin inhibitors alter loop segment chloride uptake during furosemide diuresis.

Authors:  K A Kirchner
Journal:  Am J Physiol       Date:  1985-05
View more
  6 in total

1.  Stereoselective disposition of flurbiprofen in uraemic patients.

Authors:  M P Knadler; D C Brater; S D Hall
Journal:  Br J Clin Pharmacol       Date:  1992-04       Impact factor: 4.335

Review 2.  Nonsteroidal anti-inflammatory drugs and acute renal failure in the elderly. A risk-benefit assessment.

Authors:  W Ailabouni; G Eknoyan
Journal:  Drugs Aging       Date:  1996-11       Impact factor: 3.923

Review 3.  Prostaglandin E2 modulation of blood pressure homeostasis: studies in rodent models.

Authors:  Christina E Swan; Richard M Breyer
Journal:  Prostaglandins Other Lipid Mediat       Date:  2011-07-27       Impact factor: 3.072

4.  Prostaglandin E2 inhibits renal collecting duct Na+ absorption by activating the EP1 receptor.

Authors:  Y Guan; Y Zhang; R M Breyer; B Fowler; L Davis; R L Hébert; M D Breyer
Journal:  J Clin Invest       Date:  1998-07-01       Impact factor: 14.808

Review 5.  Clinical pharmacokinetics of flurbiprofen and its enantiomers.

Authors:  N M Davies
Journal:  Clin Pharmacokinet       Date:  1995-02       Impact factor: 6.447

6.  A minimal impact of long-term S-flurbiprofen plaster application on kidney function in osteoarthritis patients.

Authors:  Noboru Otsuka; Ikuko Yataba; Isao Matsushita; Hideo Matsumoto; Yuichi Hoshino; Yoshio Terada
Journal:  Clin Exp Nephrol       Date:  2017-04-04       Impact factor: 2.801

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.